Revised SPCs: Zofran (ondansetron) preparations

Section 5.3 now includes information from embryo-foetal development studies in rats and rabbits, which did not show evidence of harm to the foetus when ondansetron was administered during the period of organogenesis.

Source:

electronic Medicines compendium